Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses

Immunology

Volumn 112, Issue 2, 2004, Pages 177-182

  Sivakumar, Pallavur V ^a   Foster, Donald C ^a   Clegg, Christopher H ^a  

^a ZYMOGENETICS INC   (United States)

Author keywords

Anti tumour responses; Cell mediated immunity; Humoral immunity; Interleukin 2 family; Interleukin 21

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CHROMOSOME 4Q; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DRUG POTENCY; DRUG POTENTIATION; GENE EXPRESSION; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; HUMANS; IMMUNITY, CELLULAR; INTERLEUKINS; LYMPHOCYTE ACTIVATION; NEOPLASMS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 2542565699     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01886.x     Document Type: Review

References (37)

1. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3:269-79.
2. Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory and effector memory CD4+ T cells. Pathol Biol (Paris) 2003; 51:64-6.
3. Di Santo JP, Kuhn R, Muller W. Common cytokine receptor gamma chain (gamma c) -dependent cytokines: understanding in vivo functions by gene targeting. Immunol Rev 1995; 148:19-34.
4. Kelly J, Leonard WJ. Immune deficiencies due to defects in cytokine signaling. Curr Allergy Asthma Rep 2003; 3:396-401.
5. Parrish-Novak J, Dillon SR, Nelson A et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000; 408:57-63.
6. Foster D, Parrish-Novak J, Fox B, Xu W. Cytokine-receptor pairing: accelerating discovery of cytokine function. Nat Rev Drug Discov 2004; 3:160-70.
7. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 1991; 88:11349-53.
8. Gurney AL, Wong SC, Henzel, WJ, de Sauvage FJ. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci USA 1995; 92:5292-6.
9. Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D, Sugamura K. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001; 167:1-5.
10. Habib T, Senadheera S, Weinberg K, Kaushansky K. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 2002; 41:8725-31.
11. Bennett F, Luxenberg D, Ling V et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003; 170:711-18.
12. Strengell M, Matikainen S, Siren J, Lehtonen A, Foster D, Julkunen I, Sareneva T. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol 2003; 170:5464-9.
13. Wurster AL, Rodgers VL, Satoskar AR, Whitters MJ, Young DA, Collins M, Grusby MJ. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 2002; 196:969-77.
14. Topp MS, Riddell SR, Akatsuka Y, Jensen MC, Blattman JN, Greenberg PD. Restoration of CD28 expression in CD28-CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production. J Exp Med 2003; 198:947-55.
15. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A 1998; 95:3810-15.
16. Waldmann T. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases. Arthritis Res 2002; 4 (Suppl. 3): S161-7.
17. Kasaian MT, Whitters MJ, Carter LL et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 2002; 16:559-69.
18. Eberl M, Engel R, Beck E, Jomaa H. Differentiation of human gamma-delta T cells towards distinct memory phenotypes. Cell Immunol 2002; 218:1-6.
19. Van Leeuwen EM, Gamadia LE, Baars PA, Remmerswaal EB, Ten Berge IJ, Van Lier RA. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8(+) T cells. J Immunol 2002; 169:5838-43.
20. Moroz A, Eppolito C, Nelson A, Clegg CH, Shrikant PA. IL-21 enhances and sustains CD8+ T cell responses to acheive durable tumor immunity: Comparative evaluation of IL-2. IL-15 and IL-21. J Immunol 2004, in press.
21. Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 2002; 169: 3600-5.
22. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15:406-11.
23. Jumper MD, Nishioka Y, Davis LS, Lipsky PE, Meek K. Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J Immunol 1995; 155:2369-78.
24. Murray R. Physiologic roles of interleukin-2, interleukin-4, and interleukin-7. Curr Opin Hematol 1996; 3:230-4.
25. Suto A, Nakajima H, Hirose K et al. Interleukin-21 prevents antigen-induced IgE production by inhibiting germline Cε transcription of IL-4-stimulated B cells. Blood 2002; 100:4565-73.
26. Ozaki KR, Spolski CG, Feng C-F et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002; 298:1630-4.
27. Mehta DS, Wurster AL, Whitters MJ, Young DA, Collins M, Grusby MJ. IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 2003; 170:4111-18.
28. Brady J, Hayakawa Y, Smyth MJ, Nutt SL. IL-21 induces the functional maturation of murine NK cells. J Immunol 2004; 172:2048-58.
29. Sivori S, Cantoni C, Parolini S, Marcenaro E, Conte R, Moretta L, Moretta A. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur J Immunol 2003; 33:3439-47.
30. Ugai S, Shimozato O, Kawamura K, Wang YQ, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther 2003; 10:187-92.
31. Ugai S, Shimozato O, Wang L, et al. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and - independent antitumor effects. Cancer Gene Ther 2003; 10:771-8.
32. Ma HL, Whitters MJ, Konz RF, Senices M, Young DA, Grusby MJ, Collins M, Dunussi-Joannopoulos K. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J Immunol 2003; 171:608-15.
33. Kishida T, Asada H, Itokawa Y et al. Interleukin (IL) -21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol Ther 2003; 8:552-8.
34. Di Carlo E, Comes A, Orengo AM, Rosso O, Meazza R, Musiani P, Colombo MP, Ferrini S. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice. J Immunol 2004; 172:1540-7.
35. Wang G, Tschoi M, Spolski R et al. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res 2003; 63:9016-22.
36. Brandt K, Bulfone-Paus S, Foster DC, Ruckert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 2003; 102:4090-8.
37. Brandt K, Bulfone-Paus S, Jenckel A, Foster DC, Paus R, Ruckert R. Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J Invest Dermatol 2003; 121:1379-82.